regeneron

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's …

Geron Corporation (GERN – Analyst Report) was in the spotlight last week with the company striking a collaboration deal with Johnson & Johnson for its sole pipeline candidate, imetelstat. Meanwhile, companies like Gilead (GILD – Analyst Report) and Regeneron (REGN – Analyst Report) remained in the news thanks to regulatory updates.Recap of the Week’s Most Important Stories1. Geron, which had […]

November 19, 2014 ByArpita Dutt american, association, biotechnology, company, corporation, fda, GILD, gilead, johnson, king, regeneron, regn Comments Off read more

Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on …

Last week, earnings remained in focus with several companies reporting their third quarter results. While AbbVie’s (ABBV – Analyst Report) results remained strong with the company raising its outlook, companies like Regeneron (REGN – Analyst Report) and Aegerion (AEGR – Analyst Report) narrowed their sales outlooks for their key products.Among all this, Geron (GERN – Analyst Report) made it to […]

November 5, 2014 ByArpita Dutt analyst, company, eylea, fda, investment, outlook, regeneron, sales Comments Off read more